Abstract: 

Proper use of medications can significantly improve patient outcomes and reduce healthcare costs, yet among patients with chronic illness, approximately 50% do not take medications as prescribed. Recent estimates suggest that a lack of adherence causes nearly 125,000 deaths, 10 percent of hospitalizations and costs the already strained healthcare system between $100–$289 billion a year. The factors that determine whether a patient will adhere to their therapy are complex and involve multiple stakeholders. 

Artificial intelligence techniques offer several compelling opportunities to improve medication adherence. The complex interplay of multiple stakeholders coupled with the unstructured nature of conversations and communications provides a rich source of data to analyze for sentiment and intent. When coupled with outcomes and actual adherence data, reinforcement learning can tailor specific recommendations and interventions to the unique challenges facing any patient adherence situation. This talk will examine the current application of AI techniques to improve patient adherence and share one example where natural language processing, predictive analytics and machine learning are being piloted to help case managers support patients living with a chronic rare disease.

Bio: 

Glenn Butcher is a global thought leader in digital and multi-channel marketing for biotech and
pharmaceutical companies. He has led global, regional, and country digital campaigns across most
therapeutic areas in companies small and large. His diverse experience has helped over 20 brands and 10 companies establish winning digital strategies and multi-channel campaigns over the past 17
years.

Glenn is credited with building out digital and multi-channel centers of excellence in several leading
biotech and pharmaceutical companies. He has also led numerous innovation programs to explore and implement social media, artificial intelligence, and digital health. He is a passionate advocate
for innovating on top of a solid foundation of core capabilities to ensure immediate impact and 
sustainable growth.

As Senior Director, Global Cystic Fibrosis Marketing at Vertex Pharmaceuticals, Glenn is leading the charge to establish and grow digital skills, teams, and platforms throughout the commercial
organization.